These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8971612)

  • 21. Simultaneous determination of chlorzoxazone, indicator of CYP2E1, and its metabolite in human serum using a new reversed-phase chromatographic column of 2-microm porous microspherical silica-gel.
    Tanaka E
    J Pharm Biomed Anal; 1998 Jan; 16(5):899-904. PubMed ID: 9535202
    [No Abstract]   [Full Text] [Related]  

  • 22. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1.
    Kharasch ED; Thummel KE; Mhyre J; Lillibridge JH
    Clin Pharmacol Ther; 1993 Jun; 53(6):643-50. PubMed ID: 8513656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of dexfenfluramine and nordexfenfluramine in urine by high-performance liquid chromatography using ultraviolet detection.
    Gross AS; Phillips AC; Boutagy J; Shenfield GM
    J Chromatogr; 1993 Nov; 621(1):115-20. PubMed ID: 8308082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of diosmin pretreatment on the pharmacokinetics of chlorzoxazone in healthy male volunteers.
    Rajnarayana K; Venkatesham A; Nagulu M; Srinivas M; Krishna DR
    Drug Metabol Drug Interact; 2008; 23(3-4):311-21. PubMed ID: 19326774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-performance liquid chromatography with electrochemical detection of chlorzoxazone and its hydroxy metabolite in serum using solid-phase extraction.
    Stewart JT; Carter HK
    J Chromatogr; 1986 Jul; 380(1):177-83. PubMed ID: 3745381
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
    Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
    Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching.
    Woolf E; Au T; Haddix H; Matuszewski B
    J Chromatogr A; 1995 Feb; 692(1-2):45-52. PubMed ID: 7719460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitive determination of midazolam and 1'-hydroxymidazolam in plasma by liquid-liquid extraction and column-switching liquid chromatography with ultraviolet absorbance detection and its application for measuring CYP3A activity.
    Yasui-Furukori N; Inoue Y; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(2):153-7. PubMed ID: 15522714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicokinetic interactions between orally ingested chlorzoxazone and inhaled acetone or toluene in male volunteers.
    Ernstgård L; Gullstrand E; Johanson G; Löf A
    Toxicol Sci; 1999 Apr; 48(2):189-96. PubMed ID: 10353310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of pramipexole (U-98,528) in human plasma and urine by high-performance liquid chromatography with electrochemical and ultraviolet detection.
    Lau YY; Hanson GD; Ichhpurani N
    J Chromatogr B Biomed Appl; 1996 Aug; 683(2):217-23. PubMed ID: 8891918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous determination of chlorzoxazone and ketoprofen in binary mixtures and in ternary mixtures containing the chlorzoxazone degradation product by reversed-phase liquid chromatography.
    Hassib ST; Mohammad MA; El-Zaher AA; El-Kady EF
    J AOAC Int; 2007; 90(3):693-9. PubMed ID: 17580621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Simultaneous determination of three probe drugs by reversed-phase high performance liquid chromatography].
    Hu JP; Yan SL; Xu YX; Zhang JN
    Se Pu; 2002 Nov; 20(6):540-2. PubMed ID: 12683003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous determination of aspirin and isosorbide 5-mononitrate in formulation by reversed phase high pressure liquid chromatography.
    Gandhimathi M; Ravi TK; Abraham A; Thomas R
    J Pharm Biomed Anal; 2003 Aug; 32(6):1145-8. PubMed ID: 12907257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of gatifloxacin in human serum and urine by high-performance liquid chromatography with ultraviolet detection.
    Overholser BR; Kays MB; Sowinski KM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Dec; 798(1):167-73. PubMed ID: 14630373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous determination of aceclofenac, paracetamol, and chlorzoxazone by RP-HPLC in pharmaceutical dosage form.
    Shaikh KA; Devkhile AB
    J Chromatogr Sci; 2008 Aug; 46(7):649-52. PubMed ID: 18718143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity.
    Ernstgård L; Warholm M; Johanson G
    Br J Clin Pharmacol; 2004 Aug; 58(2):190-200. PubMed ID: 15255802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
    Chen L; Yang CS
    Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of chlorzoxazone in humans.
    Desiraju RK; Renzi NL; Nayak RK; Ng KT
    J Pharm Sci; 1983 Sep; 72(9):991-4. PubMed ID: 6631711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of PNU 157706, a new dual inhibitor of 5alpha-reductase, in rat plasma by high-performance liquid chromatography with ultraviolet detection.
    Basileo G; Breda M; James CA
    J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):191-7. PubMed ID: 9869379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liquid chromatography in pharmaceutical analysis X: Determination of chlorzoxazone and hydroxy metabolite in plasma.
    Honigberg IL; Stewart JT; Coldren JW
    J Pharm Sci; 1979 Feb; 68(2):253-5. PubMed ID: 423105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.